Literature DB >> 23209029

Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption.

Katherine K Matthay1.   

Abstract

Isotretinoin (13-cis-retinoic acid; 13-cisRA) has been shown to significantly improve survival for children with high-risk neuroblastoma. Pharmacokinetics of isotretinoin may be negatively affected by the mode of drug administration and the dosing formula.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23209029      PMCID： PMC5892183          DOI： 10.1158/1078-0432.CCR-12-3313

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  11 in total

1.  Response of neuroblastoma to retinoic acid in vitro and in vivo.

Authors:  C P Reynolds; D J Kane; P A Einhorn; K K Matthay; V L Crouse; J R Wilbur; S B Shurin; R C Seeger
Journal:  Prog Clin Biol Res       Date:  1991

2.  Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.

Authors:  Alice L Yu; Andrew L Gilman; M Fevzi Ozkaynak; Wendy B London; Susan G Kreissman; Helen X Chen; Malcolm Smith; Barry Anderson; Judith G Villablanca; Katherine K Matthay; Hiro Shimada; Stephan A Grupp; Robert Seeger; C Patrick Reynolds; Allen Buxton; Ralph A Reisfeld; Steven D Gillies; Susan L Cohn; John M Maris; Paul M Sondel
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

3.  Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.

Authors:  A A Khan; J G Villablanca; C P Reynolds; V I Avramis
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

4.  13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.

Authors:  J Z Finklestein; M D Krailo; C Lenarsky; S Ladisch; G K Blair; C P Reynolds; A L Sitarz; G D Hammond
Journal:  Med Pediatr Oncol       Date:  1992

5.  Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Authors:  Katherine K Matthay; C Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

6.  Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.

Authors:  J G Villablanca; A A Khan; V I Avramis; R C Seeger; K K Matthay; N K Ramsay; C P Reynolds
Journal:  J Clin Oncol       Date:  1995-04       Impact factor: 44.544

7.  Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma.

Authors:  Gareth J Veal; Julie Errington; Sophie E Rowbotham; Nicola A Illingworth; Ghada Malik; Michael Cole; Ann K Daly; Andrew D J Pearson; Alan V Boddy
Journal:  Clin Cancer Res       Date:  2012-10-19       Impact factor: 12.531

8.  Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - a study of the United Kingdom Children's Cancer Study Group.

Authors:  G J Veal; M Cole; J Errington; A D J Pearson; A B M Foot; G Whyman; A V Boddy
Journal:  Br J Cancer       Date:  2007-01-16       Impact factor: 7.640

9.  Is there a role for retinoids to treat minimal residual disease in neuroblastoma?

Authors:  K K Matthay; C P Reynolds
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

10.  A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.

Authors:  J A Kohler; J Imeson; C Ellershaw; S O Lie
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640
View more
  4 in total

Review 1.  Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.

Authors:  Frank Peinemann; Elvira C van Dalen; Heike Enk; Frank Berthold
Journal:  Cochrane Database Syst Rev       Date:  2017-08-25

Review 2.  Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases.

Authors:  Nina Isoherranen; Guo Zhong
Journal:  Pharmacol Ther       Date:  2019-08-13       Impact factor: 12.310

Review 3.  Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer.

Authors:  Faith Stevison; Jing Jing; Sasmita Tripathy; Nina Isoherranen
Journal:  Adv Pharmacol       Date:  2015-05-27

4.  Transepithelial Anti-Neuroblastoma Response to Kale among Four Vegetable Juices Using In Vitro Model Co-Culture System.

Authors:  John E Piletz; Yuhan Mao; Debarshi Roy; Bilal Qizilbash; Eurielle Nkamssi; Enleyona Weir; Jessica Graham; Mary Emmanuel; Suwaira Iqbal; Kellie Brue; Bidisha Sengupta
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.